{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "25",
                "@timestamp": "2023-05-25T19:23:10.000010-04:00",
                "@year": "2023",
                "@month": "05"
            },
            "ait:date-sort": {
                "@day": "27",
                "@year": "2021",
                "@month": "07"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-source-document": {
                "@source-document-type": "tpa",
                "$": "20219006882794"
            },
            "xocs:funding-addon-generated-timestamp": "2021-08-05T14:58:03.449Z",
            "xocs:funding-text": "Conflict-of-interest disclosure: N.H. reports receiving honoraria from and serving as a consultant to Novartis. H.G. reports receiving lecture fees from and serving on the advisory board of Novartis. Z.K. reports receiving grants from Novartis. C.M.Z. reports serving as a consultant to Novartis. B.P. reports receiving travel expenses from BMS. J.S. reports serving as a consultant to Novartis. P.A., A.A., and K.T. report employment at and ownership of stock in Novartis. The remaining authors declare no competing financial interests.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60027565",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Division of Pediatric Hematology/Oncology/Stem Cell Transplantation"},
                                {"$": "Columbia University Irving Medical Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60027565",
                                "@dptid": "113323115"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2013764818-c07df74f84bef9447767a63542f31d1d",
                            "ce:source-text": "Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY",
                            "@dptid": "113323115"
                        },
                        "author": [{
                            "ce:given-name": "Nobuko",
                            "preferred-name": {
                                "ce:given-name": "Nobuko",
                                "ce:initials": "N.",
                                "ce:surname": "Hijiya",
                                "ce:indexed-name": "Hijiya N."
                            },
                            "@author-instance-id": "2013764818-531ceaaea0799efd2b2dcdc4a6247754",
                            "@seq": "1",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Hijiya",
                            "@auid": "7003575445",
                            "@orcid": "0000-0002-0199-054X",
                            "ce:indexed-name": "Hijiya N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Russian Federation",
                            "@afid": "113139706",
                            "@country": "rus",
                            "city": "Moscow",
                            "organization": [
                                {"$": "Dmitrii Rogachev Federal Research Center for Pediatric Hematology"},
                                {"$": "Oncology and Immunology"}
                            ],
                            "affiliation-id": {
                                "@afid": "113139706",
                                "@dptid": "125374854"
                            },
                            "@affiliation-instance-id": "2013764818-1ddb15d167acc577b681c381afc07901",
                            "ce:source-text": "Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation",
                            "@dptid": "125374854"
                        },
                        "author": [{
                            "ce:given-name": "Alexey",
                            "preferred-name": {
                                "ce:given-name": "Alexey",
                                "ce:initials": "A.",
                                "ce:surname": "Maschan",
                                "ce:indexed-name": "Maschan A."
                            },
                            "@author-instance-id": "2013764818-fbbbe4cecc26498e1d11d981aa248e2b",
                            "@seq": "2",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Maschan",
                            "@auid": "55915056400",
                            "@orcid": "0000-0002-0016-6698",
                            "ce:indexed-name": "Maschan A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60012306",
                            "@country": "ita",
                            "city": "Monza",
                            "organization": [
                                {"$": "Department of Pediatrics"},
                                {"$": "Pediatric Hematology Oncology Unit"},
                                {"$": "University of Milano Bicocca"},
                                {"$": "Monza Brianza per Il Bambino e la Sua Mamma (MBBM) Foundation"},
                                {"$": "Azienda Socio Sanitaria Territoriale (ASST)"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012306",
                                "@dptid": "110261952"
                            },
                            "@affiliation-instance-id": "2013764818-bc04def6401602c62b492dfe0aa59c1e",
                            "ce:source-text": "Department of Pediatrics, Pediatric Hematology Oncology Unit, University of Milano Bicocca, Monza Brianza per il Bambino e la sua Mamma (MBBM) Foundation, Azienda Socio Sanitaria Territoriale (ASST), Monza, Italy",
                            "@dptid": "110261952"
                        },
                        "author": [{
                            "ce:given-name": "Carmelo",
                            "preferred-name": {
                                "ce:given-name": "Carmelo",
                                "ce:initials": "C.",
                                "ce:surname": "Rizzari",
                                "ce:indexed-name": "Rizzari C."
                            },
                            "@author-instance-id": "2013764818-bc8876da49af30b5d4f52143d3e4229a",
                            "@seq": "3",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Rizzari",
                            "@auid": "57216193891",
                            "@orcid": "0000-0002-4828-3893",
                            "ce:indexed-name": "Rizzari C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "address-part": "Shinjuku-ku",
                            "@afid": "60025252",
                            "@country": "jpn",
                            "organization": {"$": "Keio University School of Medicine"},
                            "affiliation-id": {"@afid": "60025252"},
                            "@affiliation-instance-id": "2013764818-4face3be5e7edfab7461095d71d32c58",
                            "ce:source-text": "Keio University School of Medicine, Shinjuku-ku, Japan"
                        },
                        "author": [{
                            "ce:given-name": "Hiroyuki",
                            "preferred-name": {
                                "ce:given-name": "Hiroyuki",
                                "ce:initials": "H.",
                                "ce:surname": "Shimada",
                                "ce:indexed-name": "Shimada H."
                            },
                            "@author-instance-id": "2013764818-d971e530162d3e2b148251997b9edee1",
                            "@seq": "4",
                            "ce:initials": "H.",
                            "@date-locked": "2021-10-04T22:13:09.889",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Shimada",
                            "@auid": "55731204400",
                            "@orcid": "0000-0002-5168-3222",
                            "ce:indexed-name": "Shimada H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60016041",
                            "@country": "ita",
                            "city": "Genoa",
                            "organization": [
                                {"$": "Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)"},
                                {"$": "Istituto Giannina Gaslini"}
                            ],
                            "affiliation-id": {"@afid": "60016041"},
                            "@affiliation-instance-id": "2013764818-231d5869932e4ee8ad0b858457388c78",
                            "ce:source-text": "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Giannina Gaslini, Genoa, Italy"
                        },
                        "author": [{
                            "ce:given-name": "Carlo",
                            "preferred-name": {
                                "ce:given-name": "Carlo",
                                "ce:initials": "C.",
                                "ce:surname": "Dufour",
                                "ce:indexed-name": "Dufour C."
                            },
                            "@author-instance-id": "2013764818-c6ce95228350ccb3efc92c5a0c942333",
                            "@seq": "5",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Dufour",
                            "@auid": "7102987700",
                            "ce:indexed-name": "Dufour C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60025326",
                            "@country": "jpn",
                            "city": "Yokohama",
                            "organization": {"$": "Kanagawa Children's Medical Center"},
                            "affiliation-id": {"@afid": "60025326"},
                            "@affiliation-instance-id": "2013764818-03a74508197bde5d723eec23b470f32d",
                            "ce:source-text": "Kanagawa Children's Medical Center, Yokohama, Japan"
                        },
                        "author": [{
                            "ce:given-name": "Hiroaki",
                            "preferred-name": {
                                "ce:given-name": "Hiroaki",
                                "ce:initials": "H.",
                                "ce:surname": "Goto",
                                "ce:indexed-name": "Goto H."
                            },
                            "@author-instance-id": "2013764818-90e1843ce223de35b79f457e3d9ba855",
                            "@seq": "6",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Goto",
                            "@auid": "57214924488",
                            "ce:indexed-name": "Goto H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60000656",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Pediatrics"},
                                {"$": "Seoul National University College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000656",
                                "@dptid": "112077590"
                            },
                            "@affiliation-instance-id": "2013764818-a23f1e0f6a294b92bdc09bfbe13503b9",
                            "ce:source-text": "Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea",
                            "@dptid": "112077590"
                        },
                        "author": [{
                            "ce:given-name": "Hyoung Jin",
                            "preferred-name": {
                                "ce:given-name": "Hyoung Jin",
                                "ce:initials": "H.J.",
                                "ce:surname": "Kang",
                                "ce:indexed-name": "Kang H.J."
                            },
                            "@author-instance-id": "2013764818-e0ebe13bdf6060dc1f2b462fc51c3879",
                            "@seq": "7",
                            "ce:initials": "H.J.",
                            "@date-locked": "2021-10-08T01:16:28.233",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kang",
                            "@auid": "7404071502",
                            "ce:indexed-name": "Kang H.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60013682",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": {"$": "Seoul National University Cancer Institute"},
                            "affiliation-id": {"@afid": "60013682"},
                            "@affiliation-instance-id": "2013764818-0c0eef67e7687fc422fff05bf71a7a04",
                            "ce:source-text": "Seoul National University Cancer Institute, Seoul, South Korea"
                        },
                        "author": [{
                            "ce:given-name": "Hyoung Jin",
                            "preferred-name": {
                                "ce:given-name": "Hyoung Jin",
                                "ce:initials": "H.J.",
                                "ce:surname": "Kang",
                                "ce:indexed-name": "Kang H.J."
                            },
                            "@author-instance-id": "2013764818-e0ebe13bdf6060dc1f2b462fc51c3879",
                            "@seq": "7",
                            "ce:initials": "H.J.",
                            "@date-locked": "2021-10-08T01:16:28.233",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kang",
                            "@auid": "7404071502",
                            "ce:indexed-name": "Kang H.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60120717",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": {"$": "Seoul National University Children's Hospital"},
                            "affiliation-id": {"@afid": "60120717"},
                            "@affiliation-instance-id": "2013764818-ba3f01a30e50617a9ab19e6726c74ef8",
                            "ce:source-text": "Seoul National University Children's Hospital, Seoul, South Korea"
                        },
                        "author": [{
                            "ce:given-name": "Hyoung Jin",
                            "preferred-name": {
                                "ce:given-name": "Hyoung Jin",
                                "ce:initials": "H.J.",
                                "ce:surname": "Kang",
                                "ce:indexed-name": "Kang H.J."
                            },
                            "@author-instance-id": "2013764818-e0ebe13bdf6060dc1f2b462fc51c3879",
                            "@seq": "7",
                            "ce:initials": "H.J.",
                            "@date-locked": "2021-10-08T01:16:28.233",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kang",
                            "@auid": "7404071502",
                            "ce:indexed-name": "Kang H.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "126654722",
                            "@country": "kor",
                            "city": "Hongcheon-gun",
                            "organization": {"$": "Wide River Institute of Immunology"},
                            "affiliation-id": {"@afid": "126654722"},
                            "@affiliation-instance-id": "2013764818-65b0dc07d5d0c2a883405da1a3041830",
                            "ce:source-text": "Wide River Institute of Immunology, Hongcheon-gun, South Korea"
                        },
                        "author": [{
                            "ce:given-name": "Hyoung Jin",
                            "preferred-name": {
                                "ce:given-name": "Hyoung Jin",
                                "ce:initials": "H.J.",
                                "ce:surname": "Kang",
                                "ce:indexed-name": "Kang H.J."
                            },
                            "@author-instance-id": "2013764818-e0ebe13bdf6060dc1f2b462fc51c3879",
                            "@seq": "7",
                            "ce:initials": "H.J.",
                            "@date-locked": "2021-10-08T01:16:28.233",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kang",
                            "@auid": "7404071502",
                            "ce:indexed-name": "Kang H.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60003500",
                            "@country": "usa",
                            "city": "Columbus",
                            "organization": [
                                {"$": "Nationwide Children's Hospital"},
                                {"$": "The Ohio State University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60003500"},
                                {"@afid": "60080012"}
                            ],
                            "state": "OH",
                            "@affiliation-instance-id": "2013764818-f82b51d66570df54a990a57f75a3ad83",
                            "ce:source-text": "Nationwide Children's Hospital, The Ohio State University, Columbus, OH"
                        },
                        "author": [{
                            "ce:given-name": "Terri",
                            "preferred-name": {
                                "ce:given-name": "Terri",
                                "ce:initials": "T.",
                                "ce:surname": "Guinipero",
                                "ce:indexed-name": "Guinipero T."
                            },
                            "@author-instance-id": "2013764818-2638fa3536b8f111fdad92e0bc61199b",
                            "@seq": "8",
                            "ce:initials": "T.",
                            "@date-locked": "2021-10-08T01:16:28.233",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Guinipero",
                            "@auid": "35798274400",
                            "ce:indexed-name": "Guinipero T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Turkey",
                            "@afid": "60012324",
                            "@country": "tur",
                            "city": "Istanbul",
                            "organization": [
                                {"$": "Department of Pediatric Hematology/Oncology"},
                                {"$": "Istanbul Medical Faculty"},
                                {"$": "Istanbul University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60012324",
                                    "@dptid": "115174792"
                                },
                                {"@afid": "60028502"}
                            ],
                            "@affiliation-instance-id": "2013764818-d4a377abfe55f263e5e746775a9c316e",
                            "ce:source-text": "Department of Pediatric Hematology/Oncology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey",
                            "@dptid": "115174792"
                        },
                        "author": [{
                            "ce:given-name": "Zeynep",
                            "preferred-name": {
                                "ce:given-name": "Zeynep",
                                "ce:initials": "Z.",
                                "ce:surname": "Karakas",
                                "ce:indexed-name": "Karakas Z."
                            },
                            "@author-instance-id": "2013764818-e3a9cea02738c35a214e01be1a5df5d0",
                            "@seq": "9",
                            "ce:initials": "Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Karakas",
                            "@auid": "6602510535",
                            "ce:indexed-name": "Karakas Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60026312",
                            "@country": "esp",
                            "city": "Madrid",
                            "organization": {"$": "Hospital Niño Jesus"},
                            "affiliation-id": {"@afid": "60026312"},
                            "@affiliation-instance-id": "2013764818-335b75753f52eaf67fa339665d9bf480",
                            "ce:source-text": "Hospital Niño Jesus, Madrid, Spain"
                        },
                        "author": [{
                            "ce:given-name": "Francisco",
                            "preferred-name": {
                                "ce:given-name": "Francisco",
                                "ce:initials": "F.",
                                "ce:surname": "Bautista",
                                "ce:indexed-name": "Bautista F."
                            },
                            "@author-instance-id": "2013764818-ab0fa75349b8942674b07dbb22895eba",
                            "@seq": "10",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Bautista",
                            "@auid": "26030197700",
                            "ce:indexed-name": "Bautista F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "France",
                            "@afid": "60003362",
                            "@country": "fra",
                            "city": "Bordeaux",
                            "organization": {"$": "Groupe Hospitalier Pellegrin-Hopital des Enfants"},
                            "affiliation-id": {"@afid": "60003362"},
                            "@affiliation-instance-id": "2013764818-1a1183a7baff1f40c5c6b242e3bdfa81",
                            "ce:source-text": "Groupe Hospitalier Pellegrin-Hopital des Enfants, Bordeaux, France"
                        },
                        "author": [{
                            "ce:given-name": "Stephane",
                            "preferred-name": {
                                "ce:given-name": "Stephane",
                                "ce:initials": "S.",
                                "ce:surname": "Ducassou",
                                "ce:indexed-name": "Ducassou S."
                            },
                            "@author-instance-id": "2013764818-3455a374d26a4d227daae78b06d25f2b",
                            "@seq": "11",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ducassou",
                            "@auid": "24503118400",
                            "ce:indexed-name": "Ducassou S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60016329",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Samsung Medical Center"},
                                {"$": "Sungkyunkwan University School of Medicine"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60016329"},
                                {"@afid": "60020857"}
                            ],
                            "@affiliation-instance-id": "2013764818-8ece67ef334143a71bf9004614b54874",
                            "ce:source-text": "Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea"
                        },
                        "author": [{
                            "ce:given-name": "Keon Hee",
                            "preferred-name": {
                                "ce:given-name": "Keon Hee",
                                "ce:initials": "K.H.",
                                "ce:surname": "Yoo",
                                "ce:indexed-name": "Yoo K.H."
                            },
                            "@author-instance-id": "2013764818-96a4c694b0b50b5c29bf80dcff47a281",
                            "@seq": "12",
                            "ce:initials": "K.H.",
                            "@date-locked": "2022-11-24T09:29:16.525",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yoo",
                            "@auid": "35304229600",
                            "ce:indexed-name": "Yoo K.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Netherlands",
                            "@afid": "60015627",
                            "@country": "nld",
                            "city": "Rotterdam",
                            "organization": [
                                {"$": "Department of Pediatric Oncology/Hematology"},
                                {"$": "Erasmus Medical Center (MC)-Sophia Children's Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60015627",
                                    "@dptid": "120200193"
                                },
                                {"@afid": "60032114"}
                            ],
                            "@affiliation-instance-id": "2013764818-3e533e0f7fd5d8ecbab17e99420c3128",
                            "ce:source-text": "Department of Pediatric Oncology/Hematology, Erasmus Medical Center (MC)-Sophia Children's Hospital, Rotterdam, The Netherlands",
                            "@dptid": "120200193"
                        },
                        "author": [{
                            "ce:given-name": "Christian Michel",
                            "preferred-name": {
                                "ce:given-name": "Christian Michel",
                                "ce:initials": "C.M.",
                                "ce:surname": "Zwaan",
                                "ce:indexed-name": "Zwaan C.M."
                            },
                            "@author-instance-id": "2013764818-0d2bec9a627186138b87bc89d5600d47",
                            "@seq": "13",
                            "ce:initials": "C.M.",
                            "@date-locked": "2022-05-28T05:02:28.594",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zwaan",
                            "@auid": "35448096800",
                            "ce:indexed-name": "Zwaan C.M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Netherlands",
                            "@afid": "60273130",
                            "@country": "nld",
                            "city": "Utrecht",
                            "organization": {"$": "Princess Maxima Center for Pediatric Oncology"},
                            "affiliation-id": {"@afid": "60273130"},
                            "@affiliation-instance-id": "2013764818-b49e2068011cb7229b50b812b8647e45",
                            "ce:source-text": "Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"
                        },
                        "author": [{
                            "ce:given-name": "Christian Michel",
                            "preferred-name": {
                                "ce:given-name": "Christian Michel",
                                "ce:initials": "C.M.",
                                "ce:surname": "Zwaan",
                                "ce:indexed-name": "Zwaan C.M."
                            },
                            "@author-instance-id": "2013764818-0d2bec9a627186138b87bc89d5600d47",
                            "@seq": "13",
                            "ce:initials": "C.M.",
                            "@date-locked": "2022-05-28T05:02:28.594",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zwaan",
                            "@auid": "35448096800",
                            "ce:indexed-name": "Zwaan C.M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Netherlands",
                            "@afid": "126654222",
                            "@country": "nld",
                            "organization": {"$": "Innovative Therapies for Children with Cancer (ITCC) Consortium"},
                            "affiliation-id": {"@afid": "126654222"},
                            "@affiliation-instance-id": "2013764818-36f2048fbd1bc6a049893af7539bcd52",
                            "ce:source-text": "Innovative Therapies for Children with Cancer (ITCC) Consortium, The Netherlands"
                        },
                        "author": [{
                            "ce:given-name": "Christian Michel",
                            "preferred-name": {
                                "ce:given-name": "Christian Michel",
                                "ce:initials": "C.M.",
                                "ce:surname": "Zwaan",
                                "ce:indexed-name": "Zwaan C.M."
                            },
                            "@author-instance-id": "2013764818-0d2bec9a627186138b87bc89d5600d47",
                            "@seq": "13",
                            "ce:initials": "C.M.",
                            "@date-locked": "2022-05-28T05:02:28.594",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zwaan",
                            "@auid": "35448096800",
                            "ce:indexed-name": "Zwaan C.M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "France",
                            "@afid": "60020859",
                            "@country": "fra",
                            "city": "Poitiers",
                            "organization": [
                                {"$": "Unite d'Onco-Hematologie Pediatrique"},
                                {"$": "Centre d'Investigation Clinique (CIC) 1402 INSERM"},
                                {"$": "Centre Hospitalier Universitaire (CHU) de Poitiers"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60020859",
                                    "@dptid": "117707369"
                                },
                                {"@afid": "60000905"}
                            ],
                            "@affiliation-instance-id": "2013764818-bd3c710f9dea104a7cbc2de759412d34",
                            "ce:source-text": "Unite d'Onco-Hematologie Pediatrique, Centre d'Investigation Clinique (CIC) 1402 INSERM, Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France",
                            "@dptid": "117707369"
                        },
                        "author": [{
                            "ce:given-name": "Frederic",
                            "preferred-name": {
                                "ce:given-name": "Frederic",
                                "ce:initials": "F.",
                                "ce:surname": "Millot",
                                "ce:indexed-name": "Millot F."
                            },
                            "@author-instance-id": "2013764818-9df6761f8a8b6488b16f03c469bef7a6",
                            "@seq": "14",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Millot",
                            "@auid": "7006201993",
                            "ce:indexed-name": "Millot F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60002339",
                            "@country": "usa",
                            "city": "Atlanta",
                            "organization": [
                                {"$": "Aflac Cancer and Blood Disorders Center"},
                                {"$": "Children's Healthcare of Atlanta"},
                                {"$": "Emory University School of Medicine"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60002339"},
                                {"@afid": "60032068"},
                                {"@afid": "60002958"}
                            ],
                            "state": "GA",
                            "@affiliation-instance-id": "2013764818-cdc0c87c90d76fe6546e0ac78fc59dfa",
                            "ce:source-text": "Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA"
                        },
                        "author": [{
                            "ce:given-name": "Briana",
                            "preferred-name": {
                                "ce:given-name": "Briana",
                                "ce:initials": "B.",
                                "ce:surname": "Patterson",
                                "ce:indexed-name": "Patterson B."
                            },
                            "@author-instance-id": "2013764818-9c0cebbd3bdad1528ea74df53f26698c",
                            "@seq": "15",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Patterson",
                            "@auid": "35198577600",
                            "ce:indexed-name": "Patterson B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60017031",
                            "@country": "usa",
                            "city": "Chicago",
                            "organization": {"$": "Ann and Robert H. Lurie Children's Hospital of Chicago"},
                            "affiliation-id": {"@afid": "60017031"},
                            "state": "IL",
                            "@affiliation-instance-id": "2013764818-fb3ee8bb983bf60e8ea556b526068cd1",
                            "ce:source-text": "Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL"
                        },
                        "author": [{
                            "ce:given-name": "Jill",
                            "preferred-name": {
                                "ce:given-name": "Jill",
                                "ce:initials": "J.",
                                "ce:surname": "Samis",
                                "ce:indexed-name": "Samis J."
                            },
                            "@author-instance-id": "2013764818-5a56b51e069bfae4a93bfdbb0459e069",
                            "@seq": "16",
                            "ce:initials": "J.",
                            "@date-locked": "2021-09-24T18:33:55.429",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Samis",
                            "@auid": "57189997492",
                            "@orcid": "0000-0001-9369-1661",
                            "ce:indexed-name": "Samis J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60009968",
                            "@country": "che",
                            "city": "Basel",
                            "organization": {"$": "Novartis Pharma AG"},
                            "affiliation-id": {"@afid": "60009968"},
                            "@affiliation-instance-id": "2013764818-9ed09b38350ebc67547d7379b90a724b",
                            "ce:source-text": "Novartis Pharma AG, Basel, Switzerland"
                        },
                        "author": [
                            {
                                "ce:given-name": "Paola",
                                "preferred-name": {
                                    "ce:given-name": "Paola",
                                    "ce:initials": "P.",
                                    "ce:surname": "Aimone",
                                    "ce:indexed-name": "Aimone P."
                                },
                                "@author-instance-id": "2013764818-6430157b3763896af554ecab62283a98",
                                "@seq": "17",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Aimone",
                                "@auid": "37076680800",
                                "ce:indexed-name": "Aimone P."
                            },
                            {
                                "ce:given-name": "Alex",
                                "preferred-name": {
                                    "ce:given-name": "Alex",
                                    "ce:initials": "A.",
                                    "ce:surname": "Allepuz",
                                    "ce:indexed-name": "Allepuz A."
                                },
                                "@author-instance-id": "2013764818-5bb6e6aaaf2f80b58fc9e162ca2d888f",
                                "@seq": "18",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Allepuz",
                                "@auid": "57212201555",
                                "ce:indexed-name": "Allepuz A."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Russian Federation",
                            "@afid": "117733206",
                            "@country": "rus",
                            "city": "Moscow",
                            "organization": {"$": "Novartis Pharmaceuticals Corporation"},
                            "affiliation-id": {"@afid": "117733206"},
                            "@affiliation-instance-id": "2013764818-b0899f371921c227cb7319d8712eadbf",
                            "ce:source-text": "Novartis Pharmaceuticals Corporation, Moscow, Russian Federation"
                        },
                        "author": [{
                            "ce:given-name": "Ksenia",
                            "preferred-name": {
                                "ce:given-name": "Ksenia",
                                "ce:initials": "K.",
                                "ce:surname": "Titorenko",
                                "ce:indexed-name": "Titorenko K."
                            },
                            "@author-instance-id": "2013764818-a77e434191e68ee45dbbb91f3242a04b",
                            "@seq": "19",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Titorenko",
                            "@auid": "57221414884",
                            "@orcid": "0000-0002-5379-388X",
                            "ce:indexed-name": "Titorenko K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Clinical Research for Holistic Management in Pediatric Hematology and Oncology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "126192672"
                            },
                            "@affiliation-instance-id": "2013764818-2e186e3368e82a56e50059b9fa1a3d2e",
                            "ce:source-text": "Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "126192672"
                        },
                        "author": [{
                            "ce:given-name": "Darintr",
                            "preferred-name": {
                                "ce:given-name": "Darintr",
                                "ce:initials": "D.",
                                "ce:surname": "Sosothikul",
                                "ce:indexed-name": "Sosothikul D."
                            },
                            "@author-instance-id": "2013764818-0df8a0f8a641bf8c7b065f5ac356ab60",
                            "@seq": "20",
                            "ce:initials": "D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sosothikul",
                            "@auid": "15830686100",
                            "@orcid": "0000-0003-1097-3482",
                            "ce:indexed-name": "Sosothikul D."
                        }]
                    }
                ],
                "citation-title": "A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety",
                "abstracts": "© 2021 by The American Society of Hematology.The phase 2, open-label study (DIALOG) of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myelogenous leukemia (CML) met its coprimary end points, showing sustained nilotinib efficacy in patients with newly diagnosed (ND) or imatinib/dasatinib resistant/intolerant (R/I) CML. This update assessed growth and safety profiles in patients who had completed ≥48, 28-day treatment cycles of nilotinib 230 mg/m2 twice daily, or previously discontinued the study. Height was assessed regularly and reported using standard deviation scores (SDSs) based on World Health Organization growth charts. All data were summarized descriptively (cutoff, 6 March 2019). Overall, 33 patients in the R/I cohort and 25 patients in the ND cohort received nilotinib. Each cohort showed a negative slope in height SDS over the course of the study, indicating attenuated growth rates during nilotinib treatment: overall median change from baseline in height SDS after 48 cycles was 20.54 SDS (range, 2 1.6 to 0.4) and 20.91 SDS (21.4 to 20.1) in R/I and ND cohorts, respectively. Patients in the R/I cohort were shorter at baseline than those in the ND cohort, and remained so throughout the study. The most common all-cause adverse events were increased blood bilirubin (53.4%), headache (46.6%), pyrexia (37.9%), and increased alanine transferase (36.2%). Apart from the impact on growth, the safety profile of nilotinib was generally consistent with previous reports. This study was registered on www.clinicaltrials.gov at #NCT01844765.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "@country": "usa",
                        "city": "New York",
                        "organization": [
                            {"$": "Division of Pediatric Hematology/Oncology/Stem Cell Transplantation"},
                            {"$": "Columbia University Irving Medical Center"}
                        ],
                        "state": "NY",
                        "ce:source-text": "Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY"
                    },
                    "person": {
                        "ce:given-name": "Nobuko",
                        "ce:initials": "N.",
                        "ce:surname": "Hijiya",
                        "ce:indexed-name": "Hijiya N."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Blood Adv.",
                    "website": {"ce:e-address": {
                        "$": "https://ashpublications.org/bloodadvances/article/5/14/2925/476426/A-phase-2-study-of-nilotinib-in-pediatric-patients",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": [
                        {
                            "$": "24739537",
                            "@type": "electronic"
                        },
                        {
                            "$": "24739529",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "5",
                            "@issue": "14"
                        },
                        "pagerange": {
                            "@first": "2925",
                            "@last": "2934"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "American Society of Hematology"},
                    "sourcetitle": "Blood Advances",
                    "@srcid": "21100886825",
                    "publicationdate": {
                        "month": "07",
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "27 July 2021"
                        },
                        "day": "27"
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": "2720"
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}}
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "04",
                    "@timestamp": "BST 10:25:13",
                    "@year": "2021",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2013764818",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "934770856",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210747085",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "20212940386",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20212594470",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219006882794",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85111558326",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85111558326",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1182/bloodadvances.2020003759"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "31",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Athale U, Hijiya N, Patterson BC, et al. Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. Pediatr Blood Cancer. 2019;66(9):e27827.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85067390025",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "66",
                                    "@issue": "9"
                                },
                                "pagerange": {"@first": "e27827"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Athale",
                                        "ce:indexed-name": "Athale U"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Hijiya",
                                        "ce:indexed-name": "Hijiya N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BC",
                                        "@_fa": "true",
                                        "ce:surname": "Patterson",
                                        "ce:indexed-name": "Patterson BC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pediatr Blood Cancer"
                        },
                        "ce:source-text": "Athale U, Hijiya N, Patterson BC, et al. Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. Pediatr Blood Cancer. 2019;66(9):e27827."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hijiya N, Suttorp M. How I treat chronic myeloid leukemia in children and adolescents. Blood. 2019;133(22):2374-2384.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "How I treat chronic myeloid leukemia in children and adolescents"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85067266920",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "133",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "2374",
                                    "@last": "2384"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Hijiya",
                                    "ce:indexed-name": "Hijiya N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Suttorp",
                                    "ce:indexed-name": "Suttorp M."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Hijiya N, Suttorp M. How I treat chronic myeloid leukemia in children and adolescents. Blood. 2019;133(22):2374-2384."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "European Medicines Agency. Imatinib summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/glivecepar- product-information_en.pdf. Accessed February 2019.",
                        "@id": "3",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/product-information/glivecepar-product-information_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "77952118055",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "European Medicines Agency. Accessed February 2019",
                            "ref-sourcetitle": "Imatinib summary of product characteristics"
                        },
                        "ce:source-text": "European Medicines Agency. Imatinib summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/glivecepar- product-information_en.pdf. Accessed February 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "European Medicines Agency. Nilotinib summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/tasignaparproduct- information_en.pdf. Accessed February 2019.",
                        "@id": "4",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/product-information/tasignaparproduct-information_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "77952118055",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "European Medicines Agency. Accessed February 2019",
                            "ref-sourcetitle": "Nilotinib summary of product characteristics"
                        },
                        "ce:source-text": "European Medicines Agency. Nilotinib summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/tasignaparproduct- information_en.pdf. Accessed February 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "European Medicines Agency. Dasatinib summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/sprycelepar- product-information_en.pdf. Accessed February 2019.",
                        "@id": "5",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/product-information/sprycelepar-product-information_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "77952118055",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "European Medicines Agency. Accessed February 2019",
                            "ref-sourcetitle": "Dasatinib summary of product characteristics"
                        },
                        "ce:source-text": "European Medicines Agency. Dasatinib summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/sprycelepar- product-information_en.pdf. Accessed February 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gore L, Kearns PR, de Martino ML, et al. Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial. J Clin Oncol. 2018;36(13):1330-1338.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85046036154",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1330",
                                    "@last": "1338"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Gore",
                                        "ce:indexed-name": "Gore L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "PR",
                                        "@_fa": "true",
                                        "ce:surname": "Kearns",
                                        "ce:indexed-name": "Kearns PR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "ML",
                                        "@_fa": "true",
                                        "ce:surname": "de Martino",
                                        "ce:indexed-name": "de Martino ML"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Gore L, Kearns PR, de Martino ML, et al. Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial. J Clin Oncol. 2018;36(13):1330-1338."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hijiya N, Maschan A, Rizzari C, et al. Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia. Blood. 2019;134(23):2036-2045.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85076196337",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "2036",
                                    "@last": "2045"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Hijiya",
                                        "ce:indexed-name": "Hijiya N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Maschan",
                                        "ce:indexed-name": "Maschan A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Rizzari",
                                        "ce:indexed-name": "Rizzari C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Hijiya N, Maschan A, Rizzari C, et al. Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia. Blood. 2019;134(23):2036-2045."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Samis J, Lee P, Zimmerman D, Arceci RJ, Suttorp M, Hijiya N. Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia. Pediatr Blood Cancer. 2016;63(8):1332-1338.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84976474984",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "63",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1332",
                                    "@last": "1338"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Samis",
                                    "ce:indexed-name": "Samis J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee P"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Zimmerman",
                                    "ce:indexed-name": "Zimmerman D"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "RJ",
                                    "@_fa": "true",
                                    "ce:surname": "Arceci",
                                    "ce:indexed-name": "Arceci RJ"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Suttorp",
                                    "ce:indexed-name": "Suttorp M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Hijiya",
                                    "ce:indexed-name": "Hijiya N."
                                }
                            ]},
                            "ref-sourcetitle": "Pediatr Blood Cancer"
                        },
                        "ce:source-text": "Samis J, Lee P, Zimmerman D, Arceci RJ, Suttorp M, Hijiya N. Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia. Pediatr Blood Cancer. 2016;63(8):1332-1338."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood. 2016;127(4):392-399.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Pediatric chronic myeloid leukemia is a unique disease that requires a different approach"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84958225376",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "127",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "392",
                                    "@last": "399"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Hijiya",
                                    "ce:indexed-name": "Hijiya N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "KR",
                                    "@_fa": "true",
                                    "ce:surname": "Schultz",
                                    "ce:indexed-name": "Schultz KR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Metzler",
                                    "ce:indexed-name": "Metzler M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Millot",
                                    "ce:indexed-name": "Millot F"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Suttorp",
                                    "ce:indexed-name": "Suttorp M."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood. 2016;127(4):392-399."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Millot F, Baruchel A, Guilhot J, et al. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial. J Clin Oncol. 2011;29(20):2827-2832.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79960239202",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "20"
                                },
                                "pagerange": {
                                    "@first": "2827",
                                    "@last": "2832"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Millot",
                                        "ce:indexed-name": "Millot F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Baruchel",
                                        "ce:indexed-name": "Baruchel A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Guilhot",
                                        "ce:indexed-name": "Guilhot J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Millot F, Baruchel A, Guilhot J, et al. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial. J Clin Oncol. 2011;29(20):2827-2832."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Giona F, Putti MC, Micalizzi C, et al. Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience. Br J Haematol. 2015;170(3):398-407.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84942103657",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "170",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "398",
                                    "@last": "407"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Giona",
                                        "ce:indexed-name": "Giona F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MC",
                                        "@_fa": "true",
                                        "ce:surname": "Putti",
                                        "ce:indexed-name": "Putti MC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Micalizzi",
                                        "ce:indexed-name": "Micalizzi C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Giona F, Putti MC, Micalizzi C, et al. Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience. Br J Haematol. 2015;170(3):398-407."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Suttorp M, Schulze P, Glauche I, et al. Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia. 2018;32(7):1657-1669.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85048725252",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "1657",
                                    "@last": "1669"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Suttorp",
                                        "ce:indexed-name": "Suttorp M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Schulze",
                                        "ce:indexed-name": "Schulze P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Glauche",
                                        "ce:indexed-name": "Glauche I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Suttorp M, Schulze P, Glauche I, et al. Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia. 2018;32(7):1657-1669."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Millot F, Guilhot J, Baruchel A, et al. Growth deceleration in children treated with imatinib for chronic myeloid leukaemia. Eur J Cancer. 2014;50(18):3206-3211.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Growth deceleration in children treated with imatinib for chronic myeloid leukaemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925225766",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "50",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "3206",
                                    "@last": "3211"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Millot",
                                        "ce:indexed-name": "Millot F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Guilhot",
                                        "ce:indexed-name": "Guilhot J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Baruchel",
                                        "ce:indexed-name": "Baruchel A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Millot F, Guilhot J, Baruchel A, et al. Growth deceleration in children treated with imatinib for chronic myeloid leukaemia. Eur J Cancer. 2014;50(18):3206-3211."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sabnis HS, Keenum C, Lewis RW, et al. Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for chronic myeloid leukaemia or philadelphia chromosome-positive acute lymphoblastic leukaemia. Br J Haematol. 2019;185(4):795-799.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for chronic myeloid leukaemia or philadelphia chromosome-positive acute lymphoblastic leukaemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85056184569",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "185",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "795",
                                    "@last": "799"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HS",
                                        "@_fa": "true",
                                        "ce:surname": "Sabnis",
                                        "ce:indexed-name": "Sabnis HS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Keenum",
                                        "ce:indexed-name": "Keenum C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RW",
                                        "@_fa": "true",
                                        "ce:surname": "Lewis",
                                        "ce:indexed-name": "Lewis RW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Sabnis HS, Keenum C, Lewis RW, et al. Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for chronic myeloid leukaemia or philadelphia chromosome-positive acute lymphoblastic leukaemia. Br J Haematol. 2019;185(4):795-799."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Shima H, Tokuyama M, Tanizawa A, et al. Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia. J Pediatr. 2011;159(4):676-681.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80052790433",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "159",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "676",
                                    "@last": "681"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Shima",
                                        "ce:indexed-name": "Shima H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Tokuyama",
                                        "ce:indexed-name": "Tokuyama M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Tanizawa",
                                        "ce:indexed-name": "Tanizawa A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Pediatr"
                        },
                        "ce:source-text": "Shima H, Tokuyama M, Tanizawa A, et al. Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia. J Pediatr. 2011;159(4):676-681."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Suttorp M. The small problem when treating childhood chronic myeloid leukemia. Pediatr Hematol Oncol. 2019;36(4):187-188.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The small problem when treating childhood chronic myeloid leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85068592828",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "187",
                                    "@last": "188"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "ce:surname": "Suttorp",
                                "ce:indexed-name": "Suttorp M."
                            }]},
                            "ref-sourcetitle": "Pediatr Hematol Oncol"
                        },
                        "ce:source-text": "Suttorp M. The small problem when treating childhood chronic myeloid leukemia. Pediatr Hematol Oncol. 2019;36(4):187-188."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Patterson B, Samis J, Gore L, et al. Growth rate and endocrine effects of dasatinib therapy observed in a retrospective analysis of a phase 2 clinical trial for pediatric patients with chronic myeloid leukemia in chronic phase. HemaSphere. 2019;3(S1):161.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Growth rate and endocrine effects of dasatinib therapy observed in a retrospective analysis of a phase 2 clinical trial for pediatric patients with chronic myeloid leukemia in chronic phase"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85086709689",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "S1"
                                },
                                "pagerange": {"@first": "161"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Patterson",
                                        "ce:indexed-name": "Patterson B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Samis",
                                        "ce:indexed-name": "Samis J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Gore",
                                        "ce:indexed-name": "Gore L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "HemaSphere"
                        },
                        "ce:source-text": "Patterson B, Samis J, Gore L, et al. Growth rate and endocrine effects of dasatinib therapy observed in a retrospective analysis of a phase 2 clinical trial for pediatric patients with chronic myeloid leukemia in chronic phase. HemaSphere. 2019;3(S1):161."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hijiya N, Zwaan CM, Rizzari C, et al. Pharmacokinetics of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia or acute lymphoblastic leukemia. Clin Cancer Res. 2020;26(4):812-820.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia or acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85079406011",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "812",
                                    "@last": "820"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Hijiya",
                                        "ce:indexed-name": "Hijiya N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CM",
                                        "@_fa": "true",
                                        "ce:surname": "Zwaan",
                                        "ce:indexed-name": "Zwaan CM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Rizzari",
                                        "ce:indexed-name": "Rizzari C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Hijiya N, Zwaan CM, Rizzari C, et al. Pharmacokinetics of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia or acute lymphoblastic leukemia. Clin Cancer Res. 2020;26(4):812-820."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hijiya N, Maschan A, Colombini A, et al. A phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia: safety update after 36 cycles of treatment. HemaSphere. 2019;3(S1):161.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia: safety update after 36 cycles of treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85111613348",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "S1"
                                },
                                "pagerange": {"@first": "161"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Hijiya",
                                        "ce:indexed-name": "Hijiya N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Maschan",
                                        "ce:indexed-name": "Maschan A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Colombini",
                                        "ce:indexed-name": "Colombini A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "HemaSphere"
                        },
                        "ce:source-text": "Hijiya N, Maschan A, Colombini A, et al. A phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia: safety update after 36 cycles of treatment. HemaSphere. 2019;3(S1):161."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291-303.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1969"},
                            "ref-title": {"ref-titletext": "Variations in pattern of pubertal changes in girls"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0014524644",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "44",
                                    "@issue": "235"
                                },
                                "pagerange": {
                                    "@first": "291",
                                    "@last": "303"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "WA",
                                    "@_fa": "true",
                                    "ce:surname": "Marshall",
                                    "ce:indexed-name": "Marshall WA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JM.",
                                    "@_fa": "true",
                                    "ce:surname": "Tanner",
                                    "ce:indexed-name": "Tanner JM."
                                }
                            ]},
                            "ref-sourcetitle": "Arch Dis Child"
                        },
                        "ce:source-text": "Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291-303."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45(239):13-23.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1970"},
                            "ref-title": {"ref-titletext": "Variations in the pattern of pubertal changes in boys"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0014736650",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "45",
                                    "@issue": "239"
                                },
                                "pagerange": {
                                    "@first": "13",
                                    "@last": "23"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "WA",
                                    "@_fa": "true",
                                    "ce:surname": "Marshall",
                                    "ce:indexed-name": "Marshall WA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JM.",
                                    "@_fa": "true",
                                    "ce:surname": "Tanner",
                                    "ce:indexed-name": "Tanner JM."
                                }
                            ]},
                            "ref-sourcetitle": "Arch Dis Child"
                        },
                        "ce:source-text": "Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45(239):13-23."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "World Health Organization. The WHO child growth standards. https://www.who.int/childgrowth/standards/en/. Accessed February 2020.",
                        "@id": "22",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.who.int/childgrowth/standards/en/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "33750295736",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed February 2020",
                            "ref-sourcetitle": "The WHO child growth standards"
                        },
                        "ce:source-text": "World Health Organization. The WHO child growth standards. https://www.who.int/childgrowth/standards/en/. Accessed February 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "World Health Organization. Growth reference data for 5-19 years. 2020 http://www.who.int/growthref/en/. Accessed February 2020.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.who.int/growthref/en/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85102971350",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed February 2020",
                            "ref-sourcetitle": "Growth reference data for 5-19 years"
                        },
                        "ce:source-text": "World Health Organization. Growth reference data for 5-19 years. 2020 http://www.who.int/growthref/en/. Accessed February 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Temple R. Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf. 2006;15(4):241-243.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Hy's law: predicting serious hepatotoxicity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33646024613",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "241",
                                    "@last": "243"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "ce:surname": "Temple",
                                "ce:indexed-name": "Temple R."
                            }]},
                            "ref-sourcetitle": "Pharmacoepidemiol Drug Saf"
                        },
                        "ce:source-text": "Temple R. Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf. 2006;15(4):241-243."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Chaudhury S, Sparapani R, Hu ZH, et al. Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: a CIBMTR cohort analysis. Biol Blood Marrow Transplant. 2016;22(6):1056-1064.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: a CIBMTR cohort analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84963595294",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1056",
                                    "@last": "1064"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Chaudhury",
                                        "ce:indexed-name": "Chaudhury S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Sparapani",
                                        "ce:indexed-name": "Sparapani R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "ZH",
                                        "@_fa": "true",
                                        "ce:surname": "Hu",
                                        "ce:indexed-name": "Hu ZH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol Blood Marrow Transplant"
                        },
                        "ce:source-text": "Chaudhury S, Sparapani R, Hu ZH, et al. Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: a CIBMTR cohort analysis. Biol Blood Marrow Transplant. 2016;22(6):1056-1064."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Balakumaran J, Birk T, Golemiec B, et al. Evaluating the endometabolic and bone health effects of tyrosine kinase inhibitors in chronic myeloid leukaemia: a systematic review protocol. BMJ Open. 2019;9(9):e030092.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Evaluating the endometabolic and bone health effects of tyrosine kinase inhibitors in chronic myeloid leukaemia: a systematic review protocol"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85072128137",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "9"
                                },
                                "pagerange": {"@first": "e030092"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Balakumaran",
                                        "ce:indexed-name": "Balakumaran J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Birk",
                                        "ce:indexed-name": "Birk T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Golemiec",
                                        "ce:indexed-name": "Golemiec B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMJ Open"
                        },
                        "ce:source-text": "Balakumaran J, Birk T, Golemiec B, et al. Evaluating the endometabolic and bone health effects of tyrosine kinase inhibitors in chronic myeloid leukaemia: a systematic review protocol. BMJ Open. 2019;9(9):e030092."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zheng FY, Lu AD, Zuo YX, et al. Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia. Leuk Res. 2020;95:106405.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85086710082",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "95"},
                                "pagerange": {"@first": "106405"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "FY",
                                        "@_fa": "true",
                                        "ce:surname": "Zheng",
                                        "ce:indexed-name": "Zheng FY"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AD",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu AD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YX",
                                        "@_fa": "true",
                                        "ce:surname": "Zuo",
                                        "ce:indexed-name": "Zuo YX"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leuk Res"
                        },
                        "ce:source-text": "Zheng FY, Lu AD, Zuo YX, et al. Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia. Leuk Res. 2020;95:106405."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hochhaus A, Saglio G, Hughes TP, et al. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia. 2016;30(5):1044-1054.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84959482245",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1044",
                                    "@last": "1054"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Hochhaus",
                                        "ce:indexed-name": "Hochhaus A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Saglio",
                                        "ce:indexed-name": "Saglio G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "TP",
                                        "@_fa": "true",
                                        "ce:surname": "Hughes",
                                        "ce:indexed-name": "Hughes TP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Hochhaus A, Saglio G, Hughes TP, et al. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia. 2016;30(5):1044-1054."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kantarjian HM, Giles FJ, Bhalla KN, et al. Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results. Blood. 2011;117(4):1141-1145.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79251546724",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "117",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "1141",
                                    "@last": "1145"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HM",
                                        "@_fa": "true",
                                        "ce:surname": "Kantarjian",
                                        "ce:indexed-name": "Kantarjian HM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "FJ",
                                        "@_fa": "true",
                                        "ce:surname": "Giles",
                                        "ce:indexed-name": "Giles FJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KN",
                                        "@_fa": "true",
                                        "ce:surname": "Bhalla",
                                        "ce:indexed-name": "Bhalla KN"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Kantarjian HM, Giles FJ, Bhalla KN, et al. Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results. Blood. 2011;117(4):1141-1145."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kantarjian HM, Hochhaus A, Saglio G, et al. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial. Lancet Oncol. 2011;12(9):841-851.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80052383499",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "841",
                                    "@last": "851"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HM",
                                        "@_fa": "true",
                                        "ce:surname": "Kantarjian",
                                        "ce:indexed-name": "Kantarjian HM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Hochhaus",
                                        "ce:indexed-name": "Hochhaus A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Saglio",
                                        "ce:indexed-name": "Saglio G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Kantarjian HM, Hochhaus A, Saglio G, et al. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial. Lancet Oncol. 2011;12(9):841-851."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Moslehi JJ, Deininger M. Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia. J Clin Oncol. 2015;33(35):4210-4218.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84957552953",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "35"
                                },
                                "pagerange": {
                                    "@first": "4210",
                                    "@last": "4218"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JJ",
                                    "@_fa": "true",
                                    "ce:surname": "Moslehi",
                                    "ce:indexed-name": "Moslehi JJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Deininger",
                                    "ce:indexed-name": "Deininger M."
                                }
                            ]},
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Moslehi JJ, Deininger M. Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia. J Clin Oncol. 2015;33(35):4210-4218."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Utrecht",
            "@id": "60273130",
            "affilname": "Princess Máxima Center for Pediatric Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60273130",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60120717",
            "affilname": "Seoul National University Children's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120717",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "@id": "60027565",
            "affilname": "Columbia University Irving Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027565",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Madrid",
            "@id": "60026312",
            "affilname": "Hospital Infantil Universitario Niño Jesús",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026312",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Yokohama",
            "@id": "60025326",
            "affilname": "Kanagawa Children's Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025326",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60025252",
            "affilname": "Keio University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025252",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Poitiers",
            "@id": "60020859",
            "affilname": "Centre Hospitalier Universitaire de Poitiers",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020859",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Chicago IL",
            "@id": "60017031",
            "affilname": "Ann &amp; Robert H. Lurie Children's Hospital of Chicago",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017031",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Genoa",
            "@id": "60016041",
            "affilname": "Istituto Giannina Gaslini",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016041",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Rotterdam",
            "@id": "60015627",
            "affilname": "Erasmus MC Sophia Children's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015627",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60013682",
            "affilname": "Seoul National University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013682",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Istanbul",
            "@id": "60012324",
            "affilname": "İstanbul Tıp Fakültesi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012324",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60012306",
            "affilname": "Università degli Studi di Milano-Bicocca",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012306",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60009968",
            "affilname": "Novartis International AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Columbus",
            "@id": "60003500",
            "affilname": "The Ohio State University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003500",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bordeaux",
            "@id": "60003362",
            "affilname": "Groupe Hospitalier Pellegrin",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003362",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60002339",
            "affilname": "Emory University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002339",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60000656",
            "affilname": "Seoul National University College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000656",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Hongcheon-gun",
            "@id": "126654722",
            "affilname": "Wide River Institute of Immunology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126654722",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": null,
            "@id": "126654222",
            "affilname": "Innovative Therapies for Children with Cancer (ITCC) Consortium",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126654222",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Moscow",
            "@id": "117733206",
            "affilname": "Novartis Pharma LLC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117733206",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Moscow",
            "@id": "113139706",
            "affilname": "Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113139706",
            "affiliation-country": "Russian Federation"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85111558326",
        "dc:description": "The phase 2, open-label study (DIALOG) of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myelogenous leukemia (CML) met its coprimary end points, showing sustained nilotinib efficacy in patients with newly diagnosed (ND) or imatinib/dasatinib resistant/intolerant (R/I) CML. This update assessed growth and safety profiles in patients who had completed ≥48, 28-day treatment cycles of nilotinib 230 mg/m2 twice daily, or previously discontinued the study. Height was assessed regularly and reported using standard deviation scores (SDSs) based on World Health Organization growth charts. All data were summarized descriptively (cutoff, 6 March 2019). Overall, 33 patients in the R/I cohort and 25 patients in the ND cohort received nilotinib. Each cohort showed a negative slope in height SDS over the course of the study, indicating attenuated growth rates during nilotinib treatment: overall median change from baseline in height SDS after 48 cycles was 20.54 SDS (range, 2 1.6 to 0.4) and 20.91 SDS (21.4 to 20.1) in R/I and ND cohorts, respectively. Patients in the R/I cohort were shorter at baseline than those in the ND cohort, and remained so throughout the study. The most common all-cause adverse events were increased blood bilirubin (53.4%), headache (46.6%), pyrexia (37.9%), and increased alanine transferase (36.2%). Apart from the impact on growth, the safety profile of nilotinib was generally consistent with previous reports. This study was registered on www.clinicaltrials.gov at #NCT01844765.",
        "prism:coverDate": "2021-07-27",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85111558326",
        "dc:creator": {"author": [{
            "ce:given-name": "Nobuko",
            "preferred-name": {
                "ce:given-name": "Nobuko",
                "ce:initials": "N.",
                "ce:surname": "Hijiya",
                "ce:indexed-name": "Hijiya N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027565",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027565"
            },
            "ce:surname": "Hijiya",
            "@auid": "7003575445",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003575445",
            "ce:indexed-name": "Hijiya N."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85111558326"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111558326&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85111558326&origin=inward"
            }
        ],
        "source-id": "21100886825",
        "citedby-count": "6",
        "prism:volume": "5",
        "subtype": "ar",
        "dc:title": "A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety",
        "openaccess": "1",
        "prism:issn": "24739537 24739529",
        "publishercopyright": "© 2021 by The American Society of Hematology.",
        "prism:issueIdentifier": "14",
        "subtypeDescription": "Article",
        "prism:publicationName": "Blood Advances",
        "prism:pageRange": "2925-2934",
        "prism:endingPage": "2934",
        "openaccessFlag": "true",
        "prism:doi": "10.1182/bloodadvances.2020003759",
        "prism:startingPage": "2925",
        "dc:identifier": "SCOPUS_ID:85111558326",
        "dc:publisher": "American Society of Hematology"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Hematology",
        "@code": "2720",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Nobuko",
            "preferred-name": {
                "ce:given-name": "Nobuko",
                "ce:initials": "N.",
                "ce:surname": "Hijiya",
                "ce:indexed-name": "Hijiya N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027565",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027565"
            },
            "ce:surname": "Hijiya",
            "@auid": "7003575445",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003575445",
            "ce:indexed-name": "Hijiya N."
        },
        {
            "ce:given-name": "Alexey",
            "preferred-name": {
                "ce:given-name": "Alexey",
                "ce:initials": "A.",
                "ce:surname": "Maschan",
                "ce:indexed-name": "Maschan A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "113139706",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113139706"
            },
            "ce:surname": "Maschan",
            "@auid": "55915056400",
            "author-url": "https://api.elsevier.com/content/author/author_id/55915056400",
            "ce:indexed-name": "Maschan A."
        },
        {
            "ce:given-name": "Carmelo",
            "preferred-name": {
                "ce:given-name": "Carmelo",
                "ce:initials": "C.",
                "ce:surname": "Rizzari",
                "ce:indexed-name": "Rizzari C."
            },
            "@seq": "3",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012306",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012306"
            },
            "ce:surname": "Rizzari",
            "@auid": "57216193891",
            "author-url": "https://api.elsevier.com/content/author/author_id/57216193891",
            "ce:indexed-name": "Rizzari C."
        },
        {
            "ce:given-name": "Hiroyuki",
            "preferred-name": {
                "ce:given-name": "Hiroyuki",
                "ce:initials": "H.",
                "ce:surname": "Shimada",
                "ce:indexed-name": "Shimada H."
            },
            "@seq": "4",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025252",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025252"
            },
            "ce:surname": "Shimada",
            "@auid": "55731204400",
            "author-url": "https://api.elsevier.com/content/author/author_id/55731204400",
            "ce:indexed-name": "Shimada H."
        },
        {
            "ce:given-name": "Carlo",
            "preferred-name": {
                "ce:given-name": "Carlo",
                "ce:initials": "C.",
                "ce:surname": "Dufour",
                "ce:indexed-name": "Dufour C."
            },
            "@seq": "5",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016041",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016041"
            },
            "ce:surname": "Dufour",
            "@auid": "7102987700",
            "author-url": "https://api.elsevier.com/content/author/author_id/7102987700",
            "ce:indexed-name": "Dufour C."
        },
        {
            "ce:given-name": "Hiroaki",
            "preferred-name": {
                "ce:given-name": "Hiroaki",
                "ce:initials": "H.",
                "ce:surname": "Goto",
                "ce:indexed-name": "Goto H."
            },
            "@seq": "6",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025326",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025326"
            },
            "ce:surname": "Goto",
            "@auid": "57214924488",
            "author-url": "https://api.elsevier.com/content/author/author_id/57214924488",
            "ce:indexed-name": "Goto H."
        },
        {
            "ce:given-name": "Hyoung Jin",
            "preferred-name": {
                "ce:given-name": "Hyoung Jin",
                "ce:initials": "H.J.",
                "ce:surname": "Kang",
                "ce:indexed-name": "Kang H.J."
            },
            "@seq": "7",
            "ce:initials": "H.J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000656",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000656"
                },
                {
                    "@id": "60013682",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013682"
                },
                {
                    "@id": "60120717",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120717"
                },
                {
                    "@id": "126654722",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126654722"
                }
            ],
            "ce:surname": "Kang",
            "@auid": "7404071502",
            "author-url": "https://api.elsevier.com/content/author/author_id/7404071502",
            "ce:indexed-name": "Kang H.J."
        },
        {
            "ce:given-name": "Terri",
            "preferred-name": {
                "ce:given-name": "Terri",
                "ce:initials": "T.",
                "ce:surname": "Guinipero",
                "ce:indexed-name": "Guinipero T."
            },
            "@seq": "8",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60003500",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003500"
            },
            "ce:surname": "Guinipero",
            "@auid": "35798274400",
            "author-url": "https://api.elsevier.com/content/author/author_id/35798274400",
            "ce:indexed-name": "Guinipero T."
        },
        {
            "ce:given-name": "Zeynep",
            "preferred-name": {
                "ce:given-name": "Zeynep",
                "ce:initials": "Z.",
                "ce:surname": "Karakas",
                "ce:indexed-name": "Karakas Z."
            },
            "@seq": "9",
            "ce:initials": "Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012324",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012324"
            },
            "ce:surname": "Karakas",
            "@auid": "6602510535",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602510535",
            "ce:indexed-name": "Karakas Z."
        },
        {
            "ce:given-name": "Francisco",
            "preferred-name": {
                "ce:given-name": "Francisco",
                "ce:initials": "F.",
                "ce:surname": "Bautista",
                "ce:indexed-name": "Bautista F."
            },
            "@seq": "10",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026312",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026312"
            },
            "ce:surname": "Bautista",
            "@auid": "26030197700",
            "author-url": "https://api.elsevier.com/content/author/author_id/26030197700",
            "ce:indexed-name": "Bautista F."
        },
        {
            "ce:given-name": "Stephane",
            "preferred-name": {
                "ce:given-name": "Stephane",
                "ce:initials": "S.",
                "ce:surname": "Ducassou",
                "ce:indexed-name": "Ducassou S."
            },
            "@seq": "11",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60003362",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003362"
            },
            "ce:surname": "Ducassou",
            "@auid": "24503118400",
            "author-url": "https://api.elsevier.com/content/author/author_id/24503118400",
            "ce:indexed-name": "Ducassou S."
        },
        {
            "ce:given-name": "Keon Hee",
            "preferred-name": {
                "ce:given-name": "Keon Hee",
                "ce:initials": "K.H.",
                "ce:surname": "Yoo",
                "ce:indexed-name": "Yoo K.H."
            },
            "@seq": "12",
            "ce:initials": "K.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016329",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329"
            },
            "ce:surname": "Yoo",
            "@auid": "35304229600",
            "author-url": "https://api.elsevier.com/content/author/author_id/35304229600",
            "ce:indexed-name": "Yoo K.H."
        },
        {
            "ce:given-name": "Christian Michel",
            "preferred-name": {
                "ce:given-name": "Christian Michel",
                "ce:initials": "C.M.",
                "ce:surname": "Zwaan",
                "ce:indexed-name": "Zwaan C.M."
            },
            "@seq": "13",
            "ce:initials": "C.M.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60015627",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015627"
                },
                {
                    "@id": "60273130",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60273130"
                },
                {
                    "@id": "126654222",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126654222"
                }
            ],
            "ce:surname": "Zwaan",
            "@auid": "35448096800",
            "author-url": "https://api.elsevier.com/content/author/author_id/35448096800",
            "ce:indexed-name": "Zwaan C.M."
        },
        {
            "ce:given-name": "Frederic",
            "preferred-name": {
                "ce:given-name": "Frederic",
                "ce:initials": "F.",
                "ce:surname": "Millot",
                "ce:indexed-name": "Millot F."
            },
            "@seq": "14",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60020859",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020859"
            },
            "ce:surname": "Millot",
            "@auid": "7006201993",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006201993",
            "ce:indexed-name": "Millot F."
        },
        {
            "ce:given-name": "Briana",
            "preferred-name": {
                "ce:given-name": "Briana",
                "ce:initials": "B.",
                "ce:surname": "Patterson",
                "ce:indexed-name": "Patterson B."
            },
            "@seq": "15",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002339",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002339"
            },
            "ce:surname": "Patterson",
            "@auid": "35198577600",
            "author-url": "https://api.elsevier.com/content/author/author_id/35198577600",
            "ce:indexed-name": "Patterson B."
        },
        {
            "ce:given-name": "Jill",
            "preferred-name": {
                "ce:given-name": "Jill",
                "ce:initials": "J.",
                "ce:surname": "Samis",
                "ce:indexed-name": "Samis J."
            },
            "@seq": "16",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017031",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017031"
            },
            "ce:surname": "Samis",
            "@auid": "57189997492",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189997492",
            "ce:indexed-name": "Samis J."
        },
        {
            "ce:given-name": "Paola",
            "preferred-name": {
                "ce:given-name": "Paola",
                "ce:initials": "P.",
                "ce:surname": "Aimone",
                "ce:indexed-name": "Aimone P."
            },
            "@seq": "17",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Aimone",
            "@auid": "37076680800",
            "author-url": "https://api.elsevier.com/content/author/author_id/37076680800",
            "ce:indexed-name": "Aimone P."
        },
        {
            "ce:given-name": "Alex",
            "preferred-name": {
                "ce:given-name": "Alex",
                "ce:initials": "A.",
                "ce:surname": "Allepuz",
                "ce:indexed-name": "Allepuz A."
            },
            "@seq": "18",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Allepuz",
            "@auid": "57212201555",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212201555",
            "ce:indexed-name": "Allepuz A."
        },
        {
            "ce:given-name": "Ksenia",
            "preferred-name": {
                "ce:given-name": "Ksenia",
                "ce:initials": "K.",
                "ce:surname": "Titorenko",
                "ce:indexed-name": "Titorenko K."
            },
            "@seq": "19",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "117733206",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117733206"
            },
            "ce:surname": "Titorenko",
            "@auid": "57221414884",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221414884",
            "ce:indexed-name": "Titorenko K."
        },
        {
            "ce:given-name": "Darintr",
            "preferred-name": {
                "ce:given-name": "Darintr",
                "ce:initials": "D.",
                "ce:surname": "Sosothikul",
                "ce:indexed-name": "Sosothikul D."
            },
            "@seq": "20",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Sosothikul",
            "@auid": "15830686100",
            "author-url": "https://api.elsevier.com/content/author/author_id/15830686100",
            "ce:indexed-name": "Sosothikul D."
        }
    ]}
}}